Nevro Corp., delivering comprehensive, life-changing solutions for the treatment of chronic pain, reported its financial results for the first quarter ended March 31, 2022, provided guidance for the second quarter of 2022 and reiterated its full-year 2022 revenue guidance.
May 4, 2022
· 17 min read